Association between vitamin d deficiency and metabolic syndrome;Deficiencia de vitamina D: ¿factor de riesgo de síndrome metabólico?

Revista Medica de Chile

Volumn 138, Issue 10, 2010, Pages 1312-1318

  Querales, Marvin Isaac ^a   Cruces, María Elena ^a   Rojas, Susan ^a   Sánchez, Lissette ^a  

^a UNIVERSIDAD DE CARABOBO   (Venezuela)

Author keywords

Insulin resistance; Metabolic syndrome X; Vitamin D

Indexed keywords

VITAMIN D;

ARTICLE; HUMAN; METABOLIC SYNDROME X; METABOLISM; RISK FACTOR; VITAMIN D DEFICIENCY;

HUMANS; METABOLIC SYNDROME X; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 78751614126     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics 2003; 112: 132-5.
2. Pozzo, M. Vitamina D: Acciones no clásicas. Actualizaciones en osteología 2005; 1: 28-33.
3. Moon J, Bandy B, Davison A. Hypothesis: etiology of atherosclerosis and osteoporosis: are imbalances in the calciferol endocrine system implicated? J Am Coll Nutr 1992; 11: 567-83.
4. Pfeifer M, Begerow B, Minne H, Nachtigall D, Hansen C. Effects of a short-term Vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86: 1633-7.
5. Chiu K, Chu A, Go V, Saad M. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-5.
6. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the third national health and nutrition examination survey. Diabetes care 2004; 27: 2813-8.
7. Holick M. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease and osteoporosis. Am J Clin Nutr 2004; 79: 362-71.
8. Barsony J, Prufer K. Vitamin D receptor and retinoid X receptor interactions in motion. Vitamin Horm 2002; 65: 345-76.
9. Wang TJ, Peencina MJ, Booth SL, Jacquees PF, Ingelson E, Lanier K, et al. Vitamin D deficiency and risk cardiovascular Disease. Circulation 2008; 117: 503-11.
10. Pilz S, Marz W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, et al. Association of Vitamin D Deficiency with Heart Failure and Sudden Cardiac Death in a Large Cross-Sectional Study of Patients Referred for Coronary Angiography. J Clin Endocrinol Metab 2008; 93: 3927-35.
11. Wolf M, Shah A, Gutiérrez O, Ankers E, Monroy M, Tamez H, et al. Vitamin D levels and early mortality among incidnt hemodialysis patients. Kidney Int 2007; 72: 1004-13.
12. 3 receptor and calbindin D28K in human and rat pancreas. Am J Physiol 1994; 267: E356-60.
13. Ayesha I, Bala T, Reddy C, Raghuramulu N. Vitamin D deficiency reduces insulin secretion and turnover in rats. Diabetes Nutr Metab 2001; 14: 78-84.
14. Sergeev IN, Rhoten WB. 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic b-cell line. Endocrinology 1995; 136: 2852-61.
15. Boucher BJ. Inadequate vitamin D status: does it contribute to the disorders comprising syndrome "X". Br J Nutr 1998; 79: 315-27.
16. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003; 57: 258-61.
17. Lind L, Heanni A, Litthell H, Hvarfner A, Seorensen OH, Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995; 8: 894-901.
18. Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T. Effect of 1 alfa (OH)-vitamnin D3 on insulin secretion in diabetes mellitus. Bone Miner 1986; 1: 187-92.
19. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89: 552-72.
20. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30: 980-6.
21. Mattila C, Knekt P, Männistö S, Rissanen H, Laaksonen MA, Montonen J, et al. Serum 25-Hydroxyvitamin D concentration subsequent risk of Type 2 diabetes. Diabetes Care 2007; 30: 2569-70.
22. Di Cesar, DJ, Ploutz-Snyder R, Weinstock RS, Moses AM. Vitamin D deficiency is more common in type 2 than in type 1 diabetes. Diabetes Care 2006; 29: 174.
23. Becker B, Hullet D, O'Herrin J, Malin G, Sollinger H, DeLuca H. Vitamin D as inmunomodulatory therapy for kidney transplantation. Transplantation 2002; 74: 1204-6.
24. Lemire J, Archer D, Beck L, Spiegelber H. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995; 125: 1704S-08S.
25. Long K, Santos J. Vitamins and the regulation of the immune response. Pediatr Infect Dis J 1999; 18: 283-90.
26. Adorini L. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann NY Acad Sci 2003; 987: 258-61.
27. Rigby W, Waugh M, Graziano R. Regulation of human monocyte HLA-DR and CD4 antigen expression, and antigen presentation by 1,25-dihidroxyvitamin D3. Blood 1990; 76: 189-97.
28. Zella J, DeLuca H. Vitamin D autoimmune diabetes. J Cell Biochem 2003; 88: 216-22.
29. +2 and force generation in resistance arteries. Am J Physiol 1996; 270: H230-7.
30. Krause R, Buhring M, Hopfenmuller W, Holick M, Sharma A. Ultraviolet B and blood pressure. Lancert 1998; 352: 709-10.
31. Li Y, Kong J, Wei M, Chen Z, Liu S, Cao L. 1,25-dihydroxyvitamin D3 is a negative endocrine regulator of rennin-angiotensin system. J Clin Invest 2002; 110: 229-38.
32. Xiang W, Kong J, Chen S, Cao L, Qiao G, Zheng W, et al. Cardiac hypertrophy in vitamin D receptor Knockout mice: role of the systemic and cardiac rennin-angiotensin systems. Am J Physiol Endocrinol Metab 2005; 228: E125-32.
33. Jespersen B, Randlow A, Abrahamsen J, Fogh-Andersen N, Olsen N, Kanstrup I. Acute cardiovascular effect of 1,25-dihydroxycholecalciferol in essential hypertension. Am J Hypertrns 1998; 11: 659-66.
34. 3-induced alterations in vascular reactivity in the spontaneously hypertensive rats. Am J Med Sci 1995; 269: C443-50.
35. Pereira M, Jacobs D, Van Horn L, Slattery M, Kartashov A, Ludwig D. Dairy consumption, obesity, and the insulin resistance syndrome in young adults: the CARDIA study. JAMA 2002; 287: 2081-9.
36. Fujita T, Palmieri G. Calcium Paradox disease: calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload. J Bone Miner Metab 2000; 18: 109-25.
37. Zemel M, Shi H, Greer B, Dirienzo D, Zemel P. Regulation of adiposity by dietary calcium. FASEB J 2000; 14: 1132-8.
38. Melanson E, Sharp T, Schneider J, Donahoo W, Grunwald G, Hill J. Relation between calcium intake and fat oxidation in adult humans. Int J Obes Relat Metab Disord 2003; 77: 1448-52.
39. Wehmeir K, Beers A, Haas M, et al. Inhibition of AI gene expression by 1,25-dihydroxyvitamin D3. Biochim Biophys Acta 2005; 1737: 16-26.
40. Ford E, Ajani U, McGuire L, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005; 28: 1228-30.
41. Reis J, von Mühlen D, Kritz-Silverstein D, Wingard D, Barrett-Connor E. Vitamin D, Parathyroid hormone levels, and the prevalence of Metabolic Syndrome in community-Dwelling older adults. Diabetes Care 2007; 30: 1549-55.
42. Hjelmesaeth J, Hofs Ø D, Aasheim ET, Jenssen T, Moan J, Hager H, et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular Diabetology 2009; 8: 7.
43. Liu S, Song Y, Ford E, Manson J, Buring J, Ridker P. Dietary calcium, vitamin D, and the prevalence of Metabolic Syndrome in Middle-Aged and Older U.S. Women. Diabetes Care 2005; 28: 2926-32.
44. Oliveri MB, Ladizesky M, Mautalen CA, Alonso A, Martínez L. Seasonal variations of hydroxyvitamin D and parathyroid hormone in Ushuaia (Argentina), the southern most city of the world. Bone Miner 1993; 20: 99-108
45. Bunout D, Barrera G, Leiva L, Gattas V, de la Maza MP, Haschke F, et al. Effect of a nutritional supplementation on bone health in Chilean elderly subjects with femoral osteoporosis. J Am Coll Nutr 2006; 25: 170-7.
46. De la Maza MP, Leiva L, Barrera G, Boggiano C, Herrera T, Pérez Y, et al. Evaluación a largo plazo del estado nutricional, composición corporal y densidad mineral ósea en mujeres operadas de bypass gástrico: impacto del nivel socioeconómico. Rev Med Chile 2008; 136: 1415-23.